Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review.
Ciapponi, A; Bardach, A; Mazzoni, A; Alconada, T; Anderson, SA; Argento, FJ; Ballivian, J; Bok, K; Comandé, D; Erbelding, E; Goucher, E; KAMPMANN, B; Karron, R; Munoz, FM; Palermo, MC; PARKER, EP K; Rodriguez Cairoli, F; Santa María, V; Stergachis, AS; Voss, G; Xiong, X; Zamora, N; Zaraa, S; Berrueta, M; Buekens, PM;
2021
Vaccine, (2021).39 40 10.1016/j.vaccine.2021.08.034.
Data for: 'BCG revaccination in Malawi: 30-year follow-up of a large, randomised, double-blind placebo-controlled trial'.
GLYNN, JR; FIELDING, K; Mzembe, T; Sichali, L; Banda, L; MCLEAN, E; Kanjala, C; CRAMPIN, AC; Ponnighaus, J; Warndorff, D; FINE, P;
2021
, London School of Hygiene & Tropical Medicine (London, United Kingdom) (2021). 10.17037/DATA.00002443.
SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling study.
PROCTER, SR; ABBAS, K; FLASCHE, S; Griffiths, U; Hagedorn, B; O'REILLY, KM; CMMID COVID-19 Working Group,; JIT, M;
2021
BMC Medicine, (2021).19 1 10.1186/s12916-021-02072-8.
Modeling the effect of vaccination on selection for antibiotic resistance in Streptococcus pneumonia e.
DAVIES, NG; FLASCHE, S; JIT, M; ATKINS, KE;
2021
Science translational medicine, (2021).13 606 10.1126/scitranslmed.aaz8690.
Erratum to 'Factors influencing acceptance of vaccination during pregnancy in The Gambia and Senegal' [Vaccine 39 (2021) 3926-3934].
Johm, P; Nkoum, N; Ceesay, A; Mbaye, EH; LARSON, H; KAMPMANN, B;
2021
Vaccine, (2021).39 37 10.1016/j.vaccine.2021.07.086.
Estimating the contribution of transmission in primary healthcare clinics to community-wide TB disease incidence, and the impact of infection prevention and control interventions, in KwaZulu-Natal, South Africa.
MCCREESH, N; Karat, A; GOVENDER, I; BAISLEY, K; Diaconu, K; Yates, T; HOUBEN, RM G J; Kielmann, K; GRANT, A; WHITE, R;
2021
medRxiv (2021). 10.1101/2021.08.02.21260844.
Disregarding the restrictive vial-opening policy for BCG vaccine in Guinea-Bissau: impact and cost-effectiveness for tuberculosis mortality and all-cause mortality in children aged 0-4 years.
Thysen, SM; Fisker, AB; Byberg, S; Aaby, P; Roy, P; WHITE, R; Griffiths, U; Harris, RC;
2021
BMJ global health, (2021).6 8 10.1136/bmjgh-2021-006127.
Levels of pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: An observational study.
Chan, J; Gidding, HF; Blyth, CC; Fathima, P; Jayasinghe, S; McIntyre, PB; Moore, HC; MULHOLLAND, K; Nguyen, CD; Andrews, R; Russell, FM;
2021
PLoS medicine, (2021).18 8 10.1371/journal.pmed.1003733.
Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic.
Hotez, PJ; Batista, C; Amor, YB; Ergonul, O; Figueroa, JP; Gilbert, S; Gursel, M; Hassanain, M; Kang, G; Kaslow, DC; Kim, JH; Lall, B; LARSON, H; Naniche, D; Sheahan, T; Shoham, S; WILDER-SMITH, A; Sow, SO; Strub-Wourgaft, N; Yadav, P; Bottazzi, ME;
2021
EClinicalMedicine, (2021).39, 10.1016/j.eclinm.2021.101053.
How to Prevent Vaccines Falling Victim to Their Own Success: Intertemporal Dependency of Incidence Levels on Indirect Effects in Economic Reevaluations.
SANDMANN, F; Ramsay, M; EDMUNDS, WJ; Choi, YH; JIT, M;
2021
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, (2021).24 10 10.1016/j.jval.2021.03.022.